Search research articles
Contact Us
Filters
Showing results (221-230 of 343) with videos related to
Page
of 35
Sort By:
Arthritis Care & Research
|
January 8, 2020
Treatment-to-Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease Manifestations
Philip J Mease, Dafna D Gladman, Alexis Ogdie, et al.
Therapeutic Advances in Musculoskeletal Disease
|
December 24, 2024
The impact of psoriatic arthritis on quality of life: a systematic review
Lija James, Louise H Hailey, Rhea Suribhatla, et al.
The Journal of Rheumatology
|
August 1, 2024
Breakout Session and Report Back: Collaboration of Rheumatologists and Dermatologists for the Care of Patients With Psoriatic Disease
Daniela Kampel Stolnicki, Laura C Coates, Charlotte E Gollins, et al.
Dermatology and Therapy
|
August 17, 2024
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials
Kenneth B Gordon, Andrew Blauvelt, Hervé Bachelez, et al.
Arthritis Research & Therapy
|
April 10, 2023
Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies
Xenofon Baraliakos, Roberto Ranza, Andrew Östör, et al.
RMD Open
|
September 28, 2022
Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis
Laura C Coates, Josef S Smolen, Philip J Mease, et al.
Rheumatology (Oxford, England)
|
June 26, 2025
High prevalence of MASLD in psoriasis and psoriatic arthritis assessed with multiparametric magnetic resonance imaging
Lija James, Charlie Diamond, Hussein Al-Mossawi, et al.
The Lancet. Rheumatology
|
September 6, 2025
Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trial
Gabriele De Marco, Elizabeth M A Hensor, Philip S Helliwell, et al.
Rheumatology (Oxford, England)
|
July 27, 2013
The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics
Laura C Coates, William Tillett, David Chandler, et al.
Rheumatology (Oxford, England)
|
October 19, 2017
Remission in psoriatic arthritis-where are we now?
Laura C Coates, Philip G Conaghan, Maria Antonietta D'Agostino, et al.
Page
of 35
Search research articles
Search
Showing results (221-230 of 343) with videos related to
Sort By:
Page
of 35
Arthritis Care & Research
|
January 8, 2020
Treatment-to-Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease Manifestations
Philip J Mease, Dafna D Gladman, Alexis Ogdie, et al.
Therapeutic Advances in Musculoskeletal Disease
|
December 24, 2024
The impact of psoriatic arthritis on quality of life: a systematic review
Lija James, Louise H Hailey, Rhea Suribhatla, et al.
The Journal of Rheumatology
|
August 1, 2024
Breakout Session and Report Back: Collaboration of Rheumatologists and Dermatologists for the Care of Patients With Psoriatic Disease
Daniela Kampel Stolnicki, Laura C Coates, Charlotte E Gollins, et al.
Dermatology and Therapy
|
August 17, 2024
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials
Kenneth B Gordon, Andrew Blauvelt, Hervé Bachelez, et al.
Arthritis Research & Therapy
|
April 10, 2023
Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies
Xenofon Baraliakos, Roberto Ranza, Andrew Östör, et al.
RMD Open
|
September 28, 2022
Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis
Laura C Coates, Josef S Smolen, Philip J Mease, et al.
Rheumatology (Oxford, England)
|
June 26, 2025
High prevalence of MASLD in psoriasis and psoriatic arthritis assessed with multiparametric magnetic resonance imaging
Lija James, Charlie Diamond, Hussein Al-Mossawi, et al.
The Lancet. Rheumatology
|
September 6, 2025
Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trial
Gabriele De Marco, Elizabeth M A Hensor, Philip S Helliwell, et al.
Rheumatology (Oxford, England)
|
July 27, 2013
The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics
Laura C Coates, William Tillett, David Chandler, et al.
Rheumatology (Oxford, England)
|
October 19, 2017
Remission in psoriatic arthritis-where are we now?
Laura C Coates, Philip G Conaghan, Maria Antonietta D'Agostino, et al.
Page
of 35